Current Affairs - Science - Discussion

Gavi, the Vaccine Alliance, partnered with UNICEF to announce a breakthrough pricing agreement for the R21/Matrix-M™ malaria vaccine on November 24, 2025. This deal lowers the vaccine cost to US$ 2.99 per dose, saves up to $90 million, and enables 7 million additional children to be vaccinated by 2030. Gavi’s role includes advance financing and supporting vaccine delivery in over 24 African countries, which bear 70% of the global malaria burden. The collaboration ensures greater accessibility, equity, and rapid deployment of life-saving vaccines in high-need regions.